Zepbound, Mounjaro sales buoy Eli Lilly family endowment

1 month ago 3

• Healthcare

wellesenterprises

• Sales of Eli Lilly's blockbuster GLP-1/GIP meds Zepbound and Mounjaro, which contain tirzepatide and are approved for, respectively, weight loss and type 2 diabetes, have helped to majorly boost the drugmaker's founders family endowment.
• The Lilly Endowment's assets have grown

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. Zepbound, Mounjaro sales buoy Eli Lilly family endowment